<DOC>
	<DOC>NCT00238862</DOC>
	<brief_summary>Patients with persistent corneal epithelial defects who have not responded to conventional therapy will be randomized to treatment with either amniotic membrane transplantation or autologous serum 20%. Outcome measures will be (1) presence or absence of complete re-epithelialization within 28 days and (2) retention of intact epithelium for at least 90 days.</brief_summary>
	<brief_title>Treatment of PED With AMT and Autologous Serum</brief_title>
	<detailed_description />
	<criteria>Corneal epithelial defect of more than 14 days that has not responded to conventional therapy Under age 18 Pregnant/lactating females Patients with hemoglobin levels &lt; 12 mg/ml Patients with limbal stem cell deficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Corneal transplant</keyword>
	<keyword>Neurotrophic keratitis</keyword>
	<keyword>Post-bacterial keratitis</keyword>
	<keyword>Metaherpetic keratitis</keyword>
</DOC>